Neuland Laboratories Limited (NSE:NEULANDLAB)
19,955
-245 (-1.21%)
Oct 15, 2026, 3:29 PM IST
Neuland Laboratories Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Neuland Laboratories stock has a consensus rating of "Strong Buy" and an average price target of ₹24,679. The average 1-year stock price forecast is 23.67% higher than the current stock price, while the lowest is ₹24,100 (+20.77%) and the highest is ₹25,819 (+29.39%).
Price Target: ₹24,679 (+23.67%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Neuland Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
24.18B
from 20.23B
Increased by 19.51%
Revenue Next Year
29.06B
from 24.18B
Increased by 20.19%
EPS This Year
362.46
from 283.71
Increased by 27.76%
EPS Next Year
485.36
from 362.46
Increased by 33.91%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.